Coelho Camila Henriques, Martins Thalita Freitas, Oliveira-Pelegrin Gabriela Ravanelli, da Rocha Maria José Alves
Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, Avenida do Café s/n CEP, Ribeirão Preto, São Paulo, 14040-904, Brazil.
Departamento de Morfologia, Fisiologia e Patologia Básica, Faculdade de Odontologia, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
Pituitary. 2017 Jun;20(3):333-339. doi: 10.1007/s11102-017-0786-x.
BACKGROUND/PURPOSE: During the early phase of sepsis, hypotension is accompanied by increase of plasma vasopressin hormone (AVP) levels, which decline during the late phase. This hypotension is due in part to increase of nitric oxide (NO) synthesis by nitric oxide synthase (NOS) enzyme. Neuronal isoform of this enzyme (nNOS) is present in vasopressinergics neurons of hypothalamus, but its role in vasopressin secretion during sepsis is unknown.
We evaluated the role of nNOS in NO production and vasopressin secretion during sepsis. Wistar rats received 7-nitroindazole (50 mg/kg, i.p.), an inhibitor of nNOS activity, or vehicle and were submitted to septic stimulus by cecal ligation and puncture (CLP). At the time points 0, 4, 6, 18 and 24 h after sepsis induction the animals were decapitated and neurohypophysis and hypothalamus were removed for analysis of vasopressin content and NOS activity, respectively. Hematocrit, serum sodium, osmolality, proteins and plasmatic AVP were quantified.
Mortality was not affected by 7-nitroindazole (7-NI). Sodium and plasma proteins levels decreased after CLP and the treatment anticipated the protein loss, and delayed serum sodium decrease. Septic animals treated with 7-NI showed decrease of osmolality 4 h after CLP. Nitric oxide synthase activity in hypothalamus increased at 4 and 24 h after CLP and was reduced with 7-NI. Neurohypophysis content of AVP diminished after CLP and 7-NI did not alter this parameter. Plasma AVP levels increased at 6 h and decreased 18 and 24 h after CLP. Treatment with 7-NI did not alter plasma vasopressin levels.
We concluded that nNOS does not have a substantial role in vasopressin secretion during experimental sepsis.
背景/目的:在脓毒症早期,低血压伴随着血浆血管加压素(AVP)水平升高,而在晚期该水平下降。这种低血压部分归因于一氧化氮合酶(NOS)催化的一氧化氮(NO)合成增加。该酶的神经元亚型(nNOS)存在于下丘脑的血管加压素能神经元中,但其在脓毒症期间血管加压素分泌中的作用尚不清楚。
我们评估了nNOS在脓毒症期间NO产生和血管加压素分泌中的作用。将Wistar大鼠腹腔注射nNOS活性抑制剂7-硝基吲唑(50mg/kg)或赋形剂,然后通过盲肠结扎和穿刺(CLP)使其受到脓毒症刺激。在诱导脓毒症后的0、4、6、18和24小时时间点,将动物断头并分别取出神经垂体和下丘脑,用于分析血管加压素含量和NOS活性。对血细胞比容、血清钠、渗透压、蛋白质和血浆AVP进行定量。
7-硝基吲唑(7-NI)不影响死亡率。CLP后钠和血浆蛋白水平下降,而该治疗提前了蛋白丢失,并延迟了血清钠的下降。用7-NI治疗的脓毒症动物在CLP后4小时渗透压降低。CLP后4小时和24小时下丘脑一氧化氮合酶活性增加,而7-NI使其降低。CLP后神经垂体中AVP含量减少,7-NI未改变该参数。CLP后6小时血浆AVP水平升高,18小时和24小时下降。7-NI治疗未改变血浆血管加压素水平。
我们得出结论,在实验性脓毒症期间,nNOS在血管加压素分泌中没有实质性作用。